Legal Psilocybin Mushrooms in Oregon: A Prologue

Audra McNamee and Luca Mazzucato

Legal Psilocybin Mushrooms in Oregon Cover Legal Psilocybin Mushrooms in Oregon Page 0 Legal Psilocybin Mushrooms in Oregon Page 1 Legal Psilocybin Mushrooms in Oregon Page 2 Legal Psilocybin Mushrooms in Oregon Page 3 Legal Psilocybin Mushrooms in Oregon Page 4 Legal Psilocybin Mushrooms in Oregon Page 5 Legal Psilocybin Mushrooms in Oregon Page 6 Legal Psilocybin Mushrooms in Oregon Page 7 Legal Psilocybin Mushrooms in Oregon Page 8 Legal Psilocybin Mushrooms in Oregon Page 9 Legal Psilocybin Mushrooms in Oregon Page 10 Legal Psilocybin Mushrooms in Oregon Page 11 Legal Psilocybin Mushrooms in Oregon Page 12 Legal Psilocybin Mushrooms in Oregon Page 13 Legal Psilocybin Mushrooms in Oregon Page 14 Legal Psilocybin Mushrooms in Oregon Page 15 Legal Psilocybin Mushrooms in Oregon Page 16

Transcript

Legal Psilocybin Mushrooms in Oregon: Prologue Citations

 More about Oregon Psilocybin Services on the OHA web page, oregon.gov/psilocybin

PAGE 1:

The QR code leads to ORS 475A.

The final adopted rules can be found on the Oregon Secretary of State website, under the Oregon Health Authority Public Health Division Chapter 333, Division 333.

PAGE 2:

More about M110 is at the Oregon Health Authority’s Drug Addiction Treatment and Recovery Act (Measure 110) web page.

PAGE 3:

The QR code leads to Griffiths, Roland R et al. “Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.” Journal of Psychopharmacology (Oxford, England) vol. 30,12 (2016): 1181-1197.

Further reading:

Davis AK, Barrett FS, May DG, et al. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2021;78(5):481–489.

Oregon Psilocybin Advisory Board Rapid Evidence Review and Recommendations.

PAGE 4:

Bryan Roth, personal correspondence.

Roland Griffiths, from Michael Pollan’s How to Change Your Mind.

Monnica Williams quote from “Psychedelics and Race: A Profile of Dr. Monnica T. Williams,” written by Patricia Kubala in Society for Cultural Anthropology.

PAGE 7:

Oregon Psilocybin Advisory Board Rapid Evidence Review and Recommendations, page 12 and page 27.

PAGE 10:

The trials by organizations currently furthest on the path towards FDA approval, Usona’s PSIL201 trial for Major Depressive Disorder
and Compass Pathways’ COMP Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression, both gave 25mg of psilocybin to trial participants as the primary dose size.

PAGE 11:

Map of possible service center location from Psychedelic Alpha’s Oregon Psilocybin Services Act Local Jurisdiction Tracker.

PAGE 13:

The previously mentioned Usona and Compass Pathways trials have three and two integration sessions respectively.


About the authors

BS ’22 (mathematics and computer science). Nonfiction cartoonist in Portland, Oregon. Science and Comics Initiative Program Coordinator.

Luca Mazzucato the current co-director of the Science and Comics Initiative. Luca is also an Assistant Professor at the Departments of Biology and Mathematics, a Member of the Institute of Neuroscience, and Principle Investigator of the Mazzucato Lab.

License

Legal Psilocybin Mushrooms in Oregon: A Prologue Copyright © 2024 by Audra McNamee and Luca Mazzucato. All Rights Reserved.

Share This Book